IRWDNasdaq United States
Market cap
$711.130 M
$4.32 +1.41%
Close of 7 Aug 2026
Revenue
$296.2M
#2143 by revenue
Earnings
$24.0M
#1814 by earnings
Shares outstanding
165,239,947
Latest filing cover page
P/E ratio
29.6
Cap ÷ net income
Where these numbers come from
Share counts and financials for Ironwood Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.